| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/22/2009 | CN101415729A Antibodies against amyloid-beta peptide |
| 04/22/2009 | CN101415728A Anti-IGF-1R antibodies and uses thereof |
| 04/22/2009 | CN101415724A Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 04/22/2009 | CN101415438A TOLL like receptor 3 antagonists, methods and uses |
| 04/22/2009 | CN101415436A Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 04/22/2009 | CN101413002A Recombinant Kluyveromyces sp. expressing antibody or antibody analogue, and construction method and use thereof |
| 04/22/2009 | CN101413001A Recombinant human cystatin C genes, and expression and use thereof |
| 04/22/2009 | CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 04/22/2009 | CN101412758A Anti-ErbB2 antibodies |
| 04/22/2009 | CN101412756A Method for detecting chlorothalonil pesticide residue and detection kit therefor |
| 04/22/2009 | CN101412748A ADRA1A polypeptide with specific C-terminal and preparation of antibody thereof |
| 04/22/2009 | CN101412697A Preparation of 1-amino hydantoin derivative hapten, antigen and antibody |
| 04/22/2009 | CN101412673A Deltamethrin antigen and antibody, as well as use thereof |
| 04/22/2009 | CN101411876A Neurotoxic oligomers |
| 04/22/2009 | CN100480388C HAb18Gedomab 1 monoclonal antibody and light and heavy chain variable area genes, coding polypeptide and use |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480383C Method of detecting trichlothecene mycotoxins and reagent thereof |
| 04/22/2009 | CN100480379C Candida albicans CTD protein kinase gene and application therefor |
| 04/22/2009 | CN100480270C Fusion protein of chemoattracting small peptide and dual specific antibodies |
| 04/22/2009 | CN100480269C Anti-vegf antibodies |
| 04/22/2009 | CN100480268C IgY+IgY(Delta Fe) (H+L) horseradish peroxidase marker antibody |
| 04/22/2009 | CN100480264C Earthworm protein suppressing cancer cell accretion by road spectrum and coding sequence thereof |
| 04/22/2009 | CN100480263C Immunosuppressive receptor derived from dendritic cell, coding sequence and uses thereof |
| 04/22/2009 | CN100480260C Recombinant production of mixtures of antibodies |
| 04/22/2009 | CN100479863C Correlation of cofilin 1 and resistance to anticancer taxane chemotherapy medicine |
| 04/22/2009 | CN100479857C Anti-HIV medicine |
| 04/21/2009 | US7522162 Light harvesting optical, optoelectronic, and photovoltaic devices |
| 04/21/2009 | US7521549 Compounds |
| 04/21/2009 | US7521543 A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same |
| 04/21/2009 | US7521542 Humanized FcγRIIB-specific antibodies and methods of use thereof |
| 04/21/2009 | US7521541 A free cysteine amino acid is a cysteine residue which has been engineered into the parent antibody and is not part of a disulfide bridge; diagnostics and therapeutics; killing or inhibiting the proliferation of tumor cells or cancer cells |
| 04/21/2009 | US7521540 CYR61 compositions and methods |
| 04/21/2009 | US7521539 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 04/21/2009 | US7521533 Tryptase polypeptide and uses thereof |
| 04/21/2009 | US7521532 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment immunological and autoimmune diseases |
| 04/21/2009 | US7521530 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521258 Methods of detecting, measuring, and evaluating modulators of body weight in biological samples, and diagnostic, monitoring, and therapeutic uses thereof |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521197 Method for producing cytotoxic T-cells |
| 04/21/2009 | US7521177 Contacting the sample with a flavivirus antigen,produced by expressing a transcriptional unit encoding a Japanese encephalitis virus (JEV) signal sequence and an immunogenic flavivirus antigen of a flavivirus; detecting an increase in antigen/antibody complex formation |
| 04/21/2009 | US7521055 Detecting variant allele of human ferroportin1 gene and evaluating DNA sequence; administering inhibitor of Ferroportin1 iron transport function; oxidative damage in mammals, iron deficiency, hemochromatosis, anemia, and blood disorders; replication; administering polypeptide, immune response |
| 04/21/2009 | US7521054 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | US7521052 Administering an effective amount of an anti-IL-6 receptor antibody (anti-IL-6R antibody) and an effective amount of methotrexate (MTX) for therapy of rheumatoid arthritis |
| 04/21/2009 | US7521051 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer |
| 04/21/2009 | US7521047 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/21/2009 | US7521046 Antibody immunization therapy for treatment of atherosclerosis |
| 04/21/2009 | US7521045 Methods of inhibiting metastasis |
| 04/21/2009 | CA2399378C Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 04/21/2009 | CA2398469C Antibody for detecting mycoplasma pneumoniae |
| 04/21/2009 | CA2193641C 66 kda antigen from borrelia |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009048980A2 Emp2 antibodies and their therapeutic uses |
| 04/16/2009 | WO2009048839A2 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 04/16/2009 | WO2009048769A2 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 04/16/2009 | WO2009048539A2 Use of anti-amyloid beta antibody in ocular diseases |
| 04/16/2009 | WO2009048537A2 Humanized antibody |
| 04/16/2009 | WO2009048289A2 Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid |
| 04/16/2009 | WO2009048072A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 |
| 04/16/2009 | WO2009047360A1 Il-21 antibodies |
| 04/16/2009 | WO2009047356A1 Compositions and methods for use for antibodies against sclerostin |
| 04/16/2009 | WO2009047007A1 Cho-k1 cell line |
| 04/16/2009 | WO2009047003A1 Method and kit for rapid isolation of human foxp3+ treg cells |
| 04/16/2009 | WO2009046978A1 Protein expression from multiple nucleic acids |
| 04/16/2009 | WO2009046541A1 MODULATION OF SIRPα - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR |
| 04/16/2009 | WO2009033013A4 Antibodies against flagellin and uses thereof |
| 04/16/2009 | WO2008137881A9 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 04/16/2009 | WO2008136848A4 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 04/16/2009 | WO2008133651A3 Ablative immunotherapy |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008036449A3 Chemical antibodies for immunotherapy and imaging |
| 04/16/2009 | WO2008028002A9 Increasing nadph-dependent products |
| 04/16/2009 | WO2007110765A3 Processes for the preparation of octreotide |
| 04/16/2009 | WO2007030451A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 04/16/2009 | WO2007027748A3 C/clp antagonists and methods of use thereof |
| 04/16/2009 | WO2007019064A3 ANTI-TNFα ANTIBODIES AND METHODS OF USE |
| 04/16/2009 | WO2006138694A3 Rabbit monoclonal antibody against id1 protein |
| 04/16/2009 | WO2006138449A3 Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen |
| 04/16/2009 | WO2006127655A3 Enhancement of hydroxy fatty acid accumulation in oilseed plants |
| 04/16/2009 | WO2006122187A3 Treating and evaluating inflammatory disorders |
| 04/16/2009 | WO2006119291A3 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 04/16/2009 | WO2006113665A3 Covalent diabodies and uses thereof |
| 04/16/2009 | WO2006103639A3 Methods and reagents for identifying/isolating t regulatory (treg) cells and for treating individuals |
| 04/16/2009 | WO2006098793A3 Hslim modulates immune responses |
| 04/16/2009 | WO2006086345A3 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 04/16/2009 | WO2006083562A3 Method and multicomponent conjugates for treating cancer |
| 04/16/2009 | WO2006060021A3 Bifunctional fusion proteins containing the flt3 ligand |
| 04/16/2009 | WO2006034328A3 Wnt proteins and detection and treatment of cancer |
| 04/16/2009 | WO2006009676A3 Compositions and methods for enzymatic decolorization of chlorophyll |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | WO2005035713A3 Alternatively spliced variants of human cox1 |
| 04/16/2009 | WO2004074433A3 Rag polypeptides, nucleic acids, and their use |
| 04/16/2009 | WO2004039956A3 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090100534 Muscle lamin a/c interacting protein, gene encoding same, and uses therefor |
| 04/16/2009 | US20090099344 Preventing polypeptide loss during chromatographic purification via protease inhibitors, temperature and/or pH adjustments |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099340 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |